The effects of the novel, reversible epidermal growth factor receptor/ErbB-2 tyrosine kinase inhibitor, GW2016, on the growth of human normal and tumor-derived cell lines in vitro and in vivo.
D. Rusnak, K. Lackey, K. Affleck, E. Wood +7 more
Researcher profile · Semantic Scholar
D. Rusnak, K. Lackey, K. Affleck, E. Wood +7 more
N. Rhodes, D. Heerding, D. Duckett, D. Eberwein +18 more
Ming Xue, T. Stein, V. Barnes, N. Rhodes +1 more
P. Hesketh, D. Batchelor, M. Golant, G. Lyman +2 more
R. Paules, E. N. Levedakou, Sandra J. Wilson, C. Innes +6 more
D. Heerding, N. Rhodes, J. Leber, T. Clark +24 more
N. Rhodes, R. Paules, John D. Roberts
Yusuke Fujieda, A. Manno, Y. Hayashi, N. Rhodes +4 more
N. Chattopadhyay, A. Berger, Erik M. Koenig, Bret Bannerman +15 more
D. Rusnak, Zhi-Hong V. Lai, T. J. Lansing, N. Rhodes +2 more
Hong Lin, D. Yamashita, J. Zeng, Ren Xie +11 more
Hong Lin, D. Yamashita, J. Zeng, Ren Xie +13 more
N. Rhodes, C. Innes, F. Propst, R. Paules
C. Afshari, N. Rhodes, R. Paules, M. Mudryj
N. Rhodes, Ray Hicks, A. B. Kasenally, C. Innes +2 more
R. Paules, E. N. Levedakou, Sandra J. Wilson, Cynthia L. Innà +6 more
D. Heerding, N. Rhodes, J. Leber, A. Choudhry +21 more